Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)

Shahid Beheshti University of Medical Sciences

Status and phase: Completed; Phase 3

Conditions: Choroidal Neovascularization

Treatments: Drug: bevacizumab

Study type: Interventional

Funder types: Other

Identifiers

NCT00370786

8543

Details and patient eligibility

About

To evaluate the effect of bevacizumab for treatment of non-AMD choroidal neovascularization (CNV); eg:angioid streaks, ocular histoplasmosis, high myopia, idiopathic,etc

Enrollment: 31 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Cases with subfoveal or juxtafoveal CNV due to a non-AMD related cause.

Exclusion criteria

• Evidence of AMD

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

31 participants in 1 patient group

1

Experimental group

Treatment:

Drug: bevacizumab